Literature DB >> 412095

[The clinical value of an oral test of pancreatic function with fluorescein dilaurate (author's transl)].

H Kaffernik, P Klimkeit, P Zöfel, U Otte, J G Meyer-Bertenrath.   

Abstract

Exocrine insufficiency of the pancreas was identified by decreased splitting of the ester substrate and thus diminished excretion of fluorescein in the urine of persons with normal pancreatic function (test excretion). Unesterified fluorescein served to ascertain the standard excretion of fluorescein (= 100%). The relation of test excretion to standard excretion was expressed in %. Values of less than 20% in collected urine are pathologic. The range of 20-30% is questionable. Normal persons showed 30% or more. The method described is simple and without problems for the patient. The test was accurate in 93% of patients with a false negative in 1%. Practicability and results recommend the test as a screening method.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412095

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN: 0341-3098


  5 in total

1.  Pancreolauryl test. Evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function.

Authors:  P G Lankisch; A Schreiber; J Otto
Journal:  Dig Dis Sci       Date:  1983-06       Impact factor: 3.199

Review 2.  Exocrine pancreatic function tests.

Authors:  P G Lankisch
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

3.  Pancreolauryl test in chronic pancreatitis.

Authors:  A Panucci; C Angonese; G Del Favero; C Fabris; L Marchioro; D Basso; F Di Mario; R Naccarato
Journal:  Klin Wochenschr       Date:  1986-12-01

4.  [Oral pancreas function test with FDL in the diagnosis of chronic pancreatitis].

Authors:  P Malfertheiner; M Peter; U Junge; H Ditschuneit
Journal:  Klin Wochenschr       Date:  1983-02-15

5.  Evaluation of a tubeless pancreatic function test in patients with steatorrhoea in a district general hospital.

Authors:  S R Gould; G L Chinn; B T Nobbs; G A Lewis
Journal:  J R Soc Med       Date:  1988-05       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.